Spectrum Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The ESG score for Spectrum Pharmaceuticals Inc indicates its transparency towards the United Nations Sustainable Development Goals. The report of Spectrum Pharmaceuticals Inc incorporates information from across the web as well as from public documents by Spectrum Pharmaceuticals Inc. The webpage contains a zero-cost E,S&G analysis for Spectrum Pharmaceuticals Inc.
Spectrum Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 4.8, social score of 6.4 and governance score of 5.3.
5.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 774 | Virpax Pharmaceuticals Inc | 5.7 | High |
| 774 | Zymeworks Inc | 5.7 | High |
| 808 | Spectrum Pharmaceuticals Inc | 5.6 | High |
| 808 | Armata Pharmaceuticals Inc | 5.6 | High |
| 808 | Biostage Inc | 5.6 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Spectrum Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Spectrum Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Spectrum Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Spectrum Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Spectrum Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Spectrum Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Spectrum Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts.